edoc

Items where Division is "03 Faculty of Medicine > Departement Biomedizin > Department of Biomedicine, University Hospital Basel > Clinical Neuroimmunology (Derfuss/Lindberg)"

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type | Creators | Refereed
Jump to: Yes
Number of items at this level: 85.

Yes

Sanderson, Nicholas S. R. and Zimmermann, Maria and Eilinger, Luca and Gubser, Céline and Schaeren-Wiemers, Nicole and Lindberg, Raija L. P. and Dougan, Stephanie K. and Ploegh, Hidde L. and Kappos, Ludwig and Derfuss, Tobias. (2017) Cocapture of cognate and bystander antigens can activate autoreactive B cells. Proceedings of the National Academy of Sciences of the United States of America, 114 (4). pp. 734-739.

Decard, B. F. and Derfuss, T.. (2016) Promising Oral Compounds for the Treatment of Multiple Sclerosis: A Glance into the Future. Seminars in Neurology, 36 (2). pp. 128-139.

Derfuss, T. and Ontaneda, D. and Nicholas, J. and Meng, X. and Hawker, K.. (2016) Relapse rates in patients with multiple sclerosis treated with fingolimod: Subgroup analyses of pooled data from three phase 3 trials. Multiple Sclerosis and Related Disorders, 8. pp. 124-130.

Diebold, M. and Derfuss, T.. (2016) Immunological treatment of multiple sclerosis. Seminars in Hematology, 53 Suppl 1. pp. 54-57.

Diebold, M. and Kappos, L. and Derfuss, T.. (2016) Zelldepletion und Myeloablation bei neuroimmunologischen Erkrankungen. Nervenarzt, 87 (8). pp. 814-820.

Disanto, G. and Benkert, P. and Lorscheider, J. and Mueller, S. and Vehoff, J. and Zecca, C. and Ramseier, S. and Achtnichts, L. and Findling, O. and Nedeltchev, K. and Radue, E. W. and Sprenger, T. and Stippich, C. and Derfuss, T. and Louvion, J. F. and Kamm, C. P. and Mattle, H. P. and Lotter, C. and Du Pasquier, R. and Schluep, M. and Pot, C. and Lalive, P. H. and Yaldizli, O. and Gobbi, C. and Kappos, L. and Kuhle, J. and Smsc Scientific Board, . (2016) The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options. PLoS One, 11 (3). e0152347.

Havla, J. and Warnke, C. and Derfuss, T. and Kappos, L. and Hartung, H. P. and Hohlfeld, R.. (2016) Interdisciplinary Risk Management in the Treatment of Multiple Sclerosis. Deutsches Ärzteblatt international , 113 (51-52). pp. 879-886.

Hegen, Harald and Adrianto, Indra and Lessard, Christopher J. and Millonig, Alban and Bertolotto, Antonio and Comabella, Manuel and Giovannoni, Gavin and Guger, Michael and Hoelzl, Martina and Khalil, Michael and Fazekas, Franz and Killestein, Joep and Lindberg, Raija L.P. and Malucchi, Simona and Mehling, Matthias and Montalban, Xavier and Rudzki, Dagmar and Schautzer, Franz and Sellebjerg, Finn and Sorensen, Per Soelberg and Deisenhammer, Florian and Steinman, Lawrence and Axtell, Robert C.. (2016) Cytokine profiles show heterogeneity of interferon-β response in multiple sclerosis patients. Neurol Neuroimmunol Neuroinflamm, 3 (2). e202.

Kappos, L. and Arnold, D. L. and Bar-Or, A. and Camm, J. and Derfuss, T. and Kieseier, B. C. and Sprenger, T. and Greenough, K. and Ni, P. and Harada, T.. (2016) Safety and efficacy of amiselimod in relapsing multiple sclerosis (MOMENTUM): a randomised, double-blind, placebo-controlled phase 2 trial. The Lancet Neurology, 15 (11). pp. 1148-1159.

Kuhle, J. and Barro, C. and Andreasson, U. and Derfuss, T. and Lindberg, R. and Sandelius, A. and Liman, V. and Norgren, N. and Blennow, K. and Zetterberg, H.. (2016) Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa. Clinical Chemistry and Laboratory Medicine, 54 (10). pp. 1655-1661.

Kuhle, Jens and Barro, Christian and Disanto, Giulio and Mathias, Amandine and Soneson, Charlotte and Bonnier, Guillaume and Yaldizli, Ozgür and Regeniter, Axel and Derfuss, Tobias and Canales, Mathieu and Schluep, Myriam and Du Pasquier, Renaud A. and Krueger, Gunnar and Granziera, Cristina. (2016) Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity. Multiple Sclerosis Journal, 22 (12). pp. 1550-1559.

Meira, Maria and Sievers, Claudia and Hoffmann, Francine and Haghikia, Aiden and Rasenack, Maria and Decard, Bernhard F. and Kuhle, Jens and Derfuss, Tobias and Kappos, Ludwig and Lindberg, Raija L.P.. (2016) Natalizumab-induced POU2AF1/Spi-B upregulation: A possible route for PML development. Neurol Neuroimmunol Neuroinflamm, 3 (3). e223.

Probstel, A. K. and Kuhle, J. and Lecourt, A. C. and Vock, I. and Sanderson, N. S. and Kappos, L. and Derfuss, T.. (2016) Multiple Sclerosis and Antibodies against KIR4.1. N Engl J Med, 374 (15). pp. 1496-1498.

Rasenack, M. and Derfuss, T.. (2016) Disease activity return after natalizumab cessation in multiple sclerosis. Expert Review of Neurotherapeutics, 16 (5). pp. 587-594.

Rasenack, M. and Rychen, J. and Andelova, M. and Naegelin, Y. and Stippich, C. and Kappos, L. and Lindberg, R. L. and Sprenger, T. and Derfuss, T.. (2016) Efficacy and Safety of Fingolimod in an Unselected Patient Population. PLoS One, 11 (1). e0146190.

Rust, H. and Kuhle, J. and Kappos, L. and Derfuss, T.. (2016) Severe exacerbation of relapsing-remitting multiple sclerosis after G-CSF therapy. Neurology: Neuroimmunology & Neuroinflammation, 3 (2). e215.

Ziemssen, T. and Derfuss, T. and de Stefano, N. and Giovannoni, G. and Palavra, F. and Tomic, D. and Vollmer, T. and Schippling, S.. (2016) Optimizing treatment success in multiple sclerosis. Journal of Neurology, 263 (6). pp. 1053-1065.

Derfuss, T. and Bergvall, N. K. and Sfikas, N. and Tomic, D. L.. (2015) Efficacy of fingolimod in patients with highly active relapsing-remitting multiple sclerosis. Current Medical Research and Opinion, 31 (9). pp. 1687-1691.

Derfuss, T. and Curtin, F. and Guebelin, C. and Bridel, C. and Rasenack, M. and Matthey, A. and Du Pasquier, R. and Schluep, M. and Desmeules, J. and Lang, A. B. and Perron, H. and Faucard, R. and Porchet, H. and Hartung, H. P. and Kappos, L. and Lalive, P. H.. (2015) A phase IIa randomised clinical study of GNbAC1, a humanised monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus in multiple sclerosis patients. Multiple Sclerosis Journal, 21 (7). pp. 885-893.

Derfuss, T. and Curtin, F. and Guebelin, C. and Bridel, C. and Rasenack, M. and Matthey, A. and Du Pasquier, R. and Schluep, M. and Desmeules, J. and Lang, A. B. and Perron, H. and Faucard, R. and Porchet, H. and Hartung, H. P. and Kappos, L. and Lalive, P. H.. (2015) A phase IIa randomized clinical study testing GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis associated endogenous retrovirus in multiple sclerosis patients - a twelve month follow-up. Journal of Neuroimmunology, 285. pp. 68-70.

Giovannoni, G. and de Jong, B. and Derfuss, T. and Izquierdo, G. and Mazibrada, G. and Molyneux, P. and Nicholas, R. and Overell, J. and Ziemssen, T. and Juliusson, G.. (2015) A pragmatic approach to dealing with fingolimod-related lymphopaenia in Europe. Multiple Sclerosis and Related Disorders, 4 (1). pp. 83-84.

Kappos, Ludwig and Radue, Ernst-Wilhelm and Comi, Giancarlo and Montalban, Xavier and Butzkueven, Helmut and Wiendl, Heinz and Giovannoni, Gavin and Hartung, Hans-Peter and Derfuss, Tobias and Naegelin, Yvonne and Sprenger, Till and Mueller-Lenke, Nicole and Griffiths, Sarah and von Rosenstiel, Philipp and Gottschalk, Rebecca and Zhang, Ying and Dahlke, Frank and Tomic, Davorka. (2015) Switching from natalizumab to fingolimod: A randomized, placebo-controlled study in RRMS. Neurology, 85 (1). pp. 29-39.

Kuhle, J. and Disanto, G. and Dobson, R. and Adiutori, R. and Bianchi, L. and Topping, J. and Bestwick, J. P. and Meier, U. C. and Marta, M. and Dalla Costa, G. and Runia, T. and Evdoshenko, E. and Lazareva, N. and Thouvenot, E. and Iaffaldano, P. and Direnzo, V. and Khademi, M. and Piehl, F. and Comabella, M. and Sombekke, M. and Killestein, J. and Hegen, H. and Rauch, S. and D'Alfonso, S. and Alvarez-Cermeno, J. C. and Kleinova, P. and Horakova, D. and Roesler, R. and Lauda, F. and Llufriu, S. and Avsar, T. and Uygunoglu, U. and Altintas, A. and Saip, S. and Menge, T. and Rajda, C. and Bergamaschi, R. and Moll, N. and Khalil, M. and Marignier, R. and Dujmovic, I. and Larsson, H. and Malmestrom, C. and Scarpini, E. and Fenoglio, C. and Wergeland, S. and Laroni, A. and Annibali, V. and Romano, S. and Martinez, A. D. and Carra, A. and Salvetti, M. and Uccelli, A. and Torkildsen, O. and Myhr, K. M. and Galimberti, D. and Rejdak, K. and Lycke, J. and Frederiksen, J. L. and Drulovic, J. and Confavreux, C. and Brassat, D. and Enzinger, C. and Fuchs, S. and Bosca, I. and Pelletier, J. and Picard, C. and Colombo, E. and Franciotta, D. and Derfuss, T. and Lindberg, R. and Yaldizli, O. and Vecsei, L. and Kieseier, B. C. and Hartung, H. P. and Villoslada, P. and Siva, A. and Saiz, A. and Tumani, H. and Havrdova, E. and Villar, L. M. and Leone, M. and Barizzone, N. and Deisenhammer, F. and Teunissen, C. and Montalban, X. and Tintore, M. and Olsson, T. and Trojano, M. and Lehmann, S. and Castelnovo, G. and Lapin, S. and Hintzen, R. and Kappos, L. and Furlan, R. and Martinelli, V. and Comi, G. and Ramagopalan, S. V. and Giovannoni, G.. (2015) Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study. Multiple Sclerosis Journal, 21 (8). pp. 1013-1024.

Matsushita, T. and Madireddy, L. and Sprenger, T. and Khankhanian, P. and Magon, S. and Naegelin, Y. and Caverzasi, E. and Lindberg, R. L. and Kappos, L. and Hauser, S. L. and Oksenberg, J. R. and Henry, R. and Pelletier, D. and Baranzini, S. E.. (2015) Genetic associations with brain cortical thickness in multiple sclerosis. Genes, Brain and Behavior, 14 (2). pp. 217-227.

Probstel, A. K. and Sanderson, N. S. and Derfuss, T.. (2015) B Cells and Autoantibodies in Multiple Sclerosis. International Journal of Molecular Sciences , 16 (7). pp. 16576-16592.

Wuhrer, Manfred and Selman, Maurice H. and McDonnell, Liam A. and Kumpfel, Tania and Derfuss, Tobias and Khademi, Mohsen and Olsson, Tomas and Hohlfeld, Reinhard and Meinl, Edgar and Krumbholz, Markus. (2015) Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid. Journal of Neuroinflammation, 12. p. 235.

Zimmer, Andrea and Blauer, Cornelia and Coslovsky, Michael and Kappos, Ludwig and Derfuss, Tobias. (2015) Optimizing treatment initiation: Effects of a patient education program about fingolimod treatment on knowledge, self-efficacy and patient satisfaction. Multiple Sclerosis and Related Disorders, 4 (5). pp. 444-450.

Hegen, H. and Millonig, A. and Bertolotto, A. and Comabella, M. and Giovanonni, G. and Guger, M. and Hoelzl, M. and Khalil, M. and Killestein, J. and Lindberg, R. and Malucchi, S. and Mehling, M. and Montalban, X. and Polman, C. and Rudzki, D. and Schautzer, F. and Sellebjerg, F. and Sorensen, P. and Deisenhammer, F.. (2014) Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody development. Multiple sclerosis, Vol. 20, H. 5. pp. 577-587.

Meira, Maria and Sievers, Claudia and Hoffmann, Francine and Derfuss, Tobias and Kuhle, Jens and Kappos, Ludwig and Lindberg, Raija L. P.. (2014) MiR-126: a novel route for natalizumab action? Multiple Sclerosis Journal, 20 (10). pp. 1363-1370.

Meira, Meira and Sievers, Claudia and Hoffmann, Francine and Rasenack, Maria and Kuhle, Jens and Derfuss, Tobias and Kappos, Ludwig and Lindberg, Raija L. P.. (2014) Unraveling natalizumab effects on deregulated miR-17 expression in CD4+ T cells of patients with relapsing-remitting multiple sclerosis. Journal of Immunology Research, 2014. p. 897249.

Papadopoulou, A. and Menegola, M. and Kuhle, J. and Ramagopalan, S. V. and D'Souza, M. and Sprenger, T. and Radue, E. W. and Kappos, L. and Yaldizli, O.. (2014) Lesion-to-ventricle distance and other risk factors for the persistence of newly formed black holes in relapsing-remitting multiple sclerosis. Multiple Sclerosis Journal, 20 (3). pp. 322-330.

Waschbisch, Anne and Sanderson, Nicholas and Krumbholz, Markus and Vlad, George and Theil, Diethilde and Schwab, Stefan and Maurer, Mathias and Derfuss, Tobias. (2014) Interferon beta and vitamin D synergize to induce immunoregulatory receptors on peripheral blood monocytes of multiple sclerosis patients. PLoS ONE, 9 (12). e115488.

Weier, Katrin and Penner, Ik and Magon, Stefano and Amann, Michael and Naegelin, Yvonne and Andelova, Michaela and Derfuss, Tobias and Stippich, Christoph and Radue, Ernst-Wilhelm and Kappos, Ludwig and Sprenger, Till. (2014) Cerebellar abnormalities contribute to disability including cognitive impairment in multiple sclerosis. PLoS ONE, 9 (1). e86916.

Yaldizli, O. and Penner, I. K. and Frontzek, K. and Naegelin, Y. and Amann, M. and Papadopoulou, A. and Sprenger, T. and Kuhle, J. and Calabrese, P. and Radu, E. W. and Kappos, L. and Gass, A.. (2014) The relationship between total and regional corpus callosum atrophy, cognitive impairment and fatigue in multiple sclerosis patients. Multiple Sclerosis Journal, 20 (3). pp. 356-364.

Corporaal, S. H. and Gensicke, H. and Kuhle, J. and Kappos, L. and Allum, J. H. and Yaldizli, O.. (2013) Balance control in multiple sclerosis : correlations of trunk sway during stance and gait tests with disease severity. Gait & posture, Vol. 37, H. 1. pp. 55-60.

Derfuss, T. and Kappos, L.. (2013) Predicting PML in natalizumab-treated patients: can we do better? Journal of neurology, neurosurgery, and psychiatry, Vol. 84, H. 11. pp. 1182-1183.

Derfuss, T. and Kuhle, J. and Lindberg, R. and Kappos, L.. (2013) Natalizumab therapy for multiple sclerosis. Seminars in neurology, Vol. 33, H. 1. pp. 26-36.

Gaiottino, J. and Norgren, N. and Dobson, R. and Topping, J. and Nissim, A. and Malaspina, A. and Bestwick, J. P. and Monsch, A. U. and Regeniter, A. and Lindberg, R. L. and Kappos, L. and Leppert, D. and Petzold, A. and Giovannoni, G. and Kuhle, J.. (2013) Increased neurofilament light chain blood levels in neurodegenerative neurological diseases. PLoS ONE, Vol. 8, H. 9 , e75091.

Kuhle, J. and Malmestrom, C. and Axelsson, M. and Plattner, K. and Yaldizli, O. and Derfuss, T. and Giovannoni, G. and Kappos, L. and Lycke, J.. (2013) Neurofilament light and heavy subunits compared as therapeutic biomarkers in multiple sclerosis. Acta neurologica scandinavica, Vol. 128, H. 6 , e33-36.

Kuhle, J. and Plattner, K. and Bestwick, J. P. and Lindberg, R. L. and Ramagopalan, S. V. and Norgren, N. and Nissim, A. and Malaspina, A. and Leppert, D. and Giovannoni, G. and Kappos, L.. (2013) A comparative study of CSF neurofilament light and heavy chain protein in MS. Multiple Sclerosis Journal, 19 (12). pp. 1597-1603.

Mehling, M. and Brinkmann, V. and Burgener, A. V. and Gubser, P. and Luster, A. D. and Kappos, L. and Hess, C.. (2013) Homing frequency of human T cells inferred from peripheral blood depletion kinetics after sphingosine-1-phosphate receptor blockade. Journal of allergy and clinical immunology, Vol. 131, H. 5 , S. 1440-1443 e7.

Mehling, M. and Fritz, S. and Hafner, P. and Eichin, D. and Yonekawa, T. and Klimkait, T. and Lindberg, R. L. and Kappos, L. and Hess, C.. (2013) Preserved Antigen-Specific Immune Response in Patients with Multiple Sclerosis Responding to IFNbeta-Therapy. PLoS ONE, Vol. 8, H. 11 , e78532.

Ozcelik, S. and Fraser, G. and Castets, P. and Schaeffer, V. and Skachokova, Z. and Breu, K. and Clavaguera, F. and Sinnreich, M. and Kappos, L. and Goedert, M. and Tolnay, M. and Winkler, D. T.. (2013) Rapamycin attenuates the progression of tau pathology in P301S tau transgenic mice. PLoS ONE, Vol. 8, H. 5 , e62459.

Preiningerova, J. L. and Baumhackl, U. and Csepany, T. and Czaplinski, A. and Deisenhammer, F. and Derfuss, T. and Fabjan, T. H. and Fazekas, F. and Fuchs, S. and Havrdova, E. and Ledinek, A. H. and Illes, Z. and Jazbec, S. S. and Klimova, E. and Komoly, S. and Kurca, E. and Linnebank, M. and Lisy, L. and Mares, J. and Prochazkova, L. and Csilla, R. and Szilasiova, J. and Stourac, P. and Talab, R. and Turcani, P. and Vachova, M. and Vecsei, L. and Vodusek, D. and Zapletalova, O. and Berger, T.. (2013) Recommendations for the use of prolonged-release fampridine in patients with multiple sclerosis (MS). CNS neuroscience & therapeutics, Vol. 19, H. 5. pp. 302-306.

Ricklin, M. E. and Lorscheider, J. and Waschbisch, A. and Paroz, C. and Mehta, S. K. and Pierson, D. L. and Kuhle, J. and Fischer-Barnicol, B. and Sprenger, T. and Lindberg, R. L. and Kappos, L. and Derfuss, T.. (2013) T-cell response against varicella-zoster virus in fingolimod-treated MS patients. Neurology, Vol. 81, H. 2. pp. 174-181.

Vaney, C. and Derfuss, T.. (2013) Was gibt‘s Neues in der kausalen Behandlung der Multiplen Sklerose? Revue médicale suisse, Vol. 9, no. 371. pp. 285-287.

Waschbisch, A. and Atiya, M. and Schaub, C. and Derfuss, T. and Schwab, S. and Lee, D. H. and Muller, M. and Linker, R. A.. (2013) Aquaporin-4 antibody negative recurrent isolated optic neuritis: clinical evidence for disease heterogeneity. Journal of the neurological sciences, Vol. 331, No. 1-2. pp. 72-75.

Derfuss, T.. (2012) Personalized medicine in multiple sclerosis: hope or reality? BMC medicine, Vol. 10 , 116.

Derfuss, T. and Kappos, L.. (2012) Evaluating the potential benefit of interferon treatment in multiple sclerosis. JAMA, Vol. 308, H. 3. pp. 290-291.

Derfuss, T. and Meinl, E.. (2012) Identifying autoantigens in demyelinating diseases : valuable clues to diagnosis and treatment? Current opinion in neurology, Vol. 25, H. 3. pp. 231-238.

Fanchamps, M. H. and Gensicke, H. and Kuhle, J. and Kappos, L. and Allum, J. H. and Yaldizli, O.. (2012) Screening for balance disorders in mildly affected multiple sclerosis patients. Journal of neurology, Vol. 259, H. 7. pp. 1413-1419.

Gensicke, H. and Leppert, D. and Yaldizli, O. and Lindberg, R. L. and Mehling, M. and Kappos, L. and Kuhle, J.. (2012) Monoclonal Antibodies and Recombinant Immunoglobulins for the Treatment of Multiple Sclerosis. CNS Drugs, 26 (1). pp. 11-37.

Held, K. and Eiglmeier, I. and Himmelein, S. and Sinicina, I. and Brandt, T. and Theil, D. and Dornmair, K. and Derfuss, T.. (2012) Clonal expansions of CD8(+) T cells in latently HSV-1-infected human trigeminal ganglia. Journal of neurovirology, Vol. 18, H. 1. pp. 62-68.

Krumbholz, M. and Derfuss, T. and Hohlfeld, R. and Meinl, E.. (2012) B cells and antibodies in multiple sclerosis pathogenesis and therapy. Nature reviews. Neurology, Vol. 8, H. 11. pp. 613-623.

Ng, J. K. and Malotka, J. and Kawakami, N. and Derfuss, T. and Khademi, M. and Olsson, T. and Linington, C. and Odaka, M. and Tackenberg, B. and Pruss, H. and Schwab, J. M. and Harms, L. and Harms, H. and Sommer, C. and Rasband, M. N. and Eshed-Eisenbach, Y. and Peles, E. and Hohlfeld, R. and Yuki, N. and Dornmair, K. and Meinl, E.. (2012) Neurofascin as a target for autoantibodies in peripheral neuropathies. Neurology, Vol. 79, H. 23. pp. 2241-2248.

Rejdak, K. and Kuhle, J. and Ruegg, S. and Lindberg, R. L. and Petzold, A. and Sulejczak, D. and Papuc, E. and Rejdak, R. and Stelmasiak, Z. and Grieb, P.. (2012) Neurofilament heavy chain and heat shock protein 70 as markers of seizure-related brain injury. Epilepsia, Vol. 53, H. 5. pp. 922-927.

Sievers, C. and Meira, M. and Hoffmann, F. and Fontoura, P. and Kappos, L. and Lindberg, R. L.. (2012) Altered microRNA expression in B lymphocytes in multiple sclerosis: towards a better understanding of treatment effects. Clinical immunology, Vol. 144, H. 1. pp. 70-79.

Weier, K. and Beck, A. and Magon, S. and Amann, M. and Naegelin, Y. and Penner, I. K. and Thurling, M. and Aurich, V. and Derfuss, T. and Radue, E. W. and Stippich, C. and Kappos, L. and Timmann, D. and Sprenger, T.. (2012) Evaluation of a new approach for semi-automatic segmentation of the cerebellum in patients with multiple sclerosis. Journal of neurology, Vol. 259, H. 12. pp. 2673-2680.

Kuhle, Jens and Gosert, Rainer and Buhler, R. and Derfuss, Tobias and Sutter, R and Yaldizli, Ozgür and Radue, E. W. and Ryschkewitsch, C. and Major, E. O. and Kappos, Ludwig and Frank, Stephan and Hirsch, Hans H.. (2011) Management and outcome of CSF-JC virus PCR-negative PML in a natalizumab-treated patient with MS. Neurology, 77 (23). pp. 2010-2016.

Held, Kathrin and Derfuss, Tobias. (2011) Control of HSV-1 latency in human trigeminal ganglia-current overview. Journal of neurovirology, Vol. 17, H. 6. pp. 518-527.

Held, Kathrin and Junker, Andreas and Dornmair, Klaus and Meinl, Edgar and Sinicina, Inga and Brandt, Thomas and Theil, Diethilde and Derfuss, Tobias. (2011) Expression of herpes simplex virus 1-encoded microRNAs in human trigeminal ganglia and their relation to local T-cell infiltrates. Journal of virology, Vol. 85, H. 19. pp. 9680-9685.

Kappos, L. and Bates, D. and Edan, G. and Eraksoy, M. and Garcia-Merino, A. and Grigoriadis, N. and Hartung, H. P. and Havrdova, E. and Hillert, J. and Hohlfeld, R. and Kremenchutzky, M. and Lyon-Caen, O. and Miller, A. and Pozzilli, C. and Ravnborg, M. and Saida, T. and Sindic, C. and Vass, K. and Clifford, D. B. and Hauser, S. and Major, E. O. and O'Connor, P. W. and Weiner, H. L. and Clanet, M. and Gold, R. and Hirsch, H. H. and Radu, E. W. and Sorensen, P. S. and King, J.. (2011) Natalizumab treatment for multiple sclerosis : updated recommendations for patient selection and monitoring. The Lancet neurology, Vol. 10, H. 8. pp. 745-758.

Kuhle, J. and Leppert, D. and Petzold, A. and Regeniter, A. and Schindler, C. and Mehling, M. and Anthony, D. C. and Kappos, L. and Lindberg, R. L.. (2011) Neurofilament heavy chain in CSF correlates with relapses and disability in multiple sclerosis. Neurology, Vol. 76, H. 14. pp. 1206-1213.

Mehling, M. and Hilbert, P. and Fritz, S. and Durovic, B. and Eichin, D. and Gasser, O. and Kuhle, J. and Klimkait, T. and Lindberg, R. L. P. and Kappos, L. and Hess, C.. (2011) Antigen-specific adaptive immune responses in fingolimod-treated multiple sclerosis patients. Annals of neurology, Vol. 69, H. 2. pp. 408-413.

Mehling, M. and Johnson, T. A. and Antel, J. and Kappos, L. and Bar-Or, A.. (2011) Clinical immunology of the sphingosine 1-phosphate receptor modulator fingolimod (FTY720) in multiple sclerosis. Neurology, Vol. 76, H. 8, Suppl. 3 , S20-S27.

Mehling, Matthias and Kappos, Ludwig and Derfuss, Tobias. (2011) Fingolimod for multiple sclerosis: mechanism of action, clinical outcomes, and future directions. Current Neurology and Neuroscience Reports, 11 (5). pp. 492-497.

Meinl, Edgar and Derfuss, Tobias and Krumbholz, Markus and Pröbstel, Anne-Katrin and Hohlfeld, Reinhard. (2011) Humoral autoimmunity in multiple sclerosis. Journal of the neurological sciences, Vol. 306, No. 1/2. pp. 180-182.

Osthoff, M. and Katan, M. and Fluri, F. and Schuetz, P. and Bingisser, R. and Kappos, L. and Steck, A. J. and Engelter, S. T. and Mueller, B. and Christ-Crain, M. and Trendelenburg, M.. (2011) Mannose-binding lectin deficiency is associated with smaller infarction size and favorable outcome in ischemic stroke patients. PLoS ONE, Vol. 6, H. 6 , e21338.

Probstel, A. K. and Dornmair, K. and Bittner, R. and Sperl, P. and Jenne, D. and Magalhaes, S. and Villalobos, A. and Breithaupt, C. and Weissert, R. and Jacob, U. and Krumbholz, M. and Kuempfel, T. and Blaschek, A. and Stark, W. and Gartner, J. and Pohl, D. and Rostasy, K. and Weber, F. and Forne, I. and Khademi, M. and Olsson, T. and Brilot, F. and Tantsis, E. and Dale, R. C. and Wekerle, H. and Hohlfeld, R. and Banwell, B. and Bar-Or, A. and Meinl, E. and Derfuss, T.. (2011) Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis. Neurology, 77 (6). pp. 580-588.

Waschbisch, Anne and Atiya, Monika and Linker, Ralf A. and Potapov, Sergej and Schwab, Stefan and Derfuss, Tobias. (2011) Glatiramer acetate treatment normalizes deregulated microRNA expression in relapsing remitting multiple sclerosis. PLoS ONE, Vol. 6, H. 9 , e24604.

Arbusow, Viktor and Derfuss, Tobias and Held, Kathrin and Himmelein, Susanne and Strupp, Michael and Gurkov, Robert and Brandt, Thomas and Theil, Diethilde. (2010) Latency of herpes simplex virus type-1 in human geniculate and vestibular ganglia is associated with infiltration of CD8+ T cells. Journal of medical virology, Vol. 82, H. 11. pp. 1917-1920.

Derfuss, Tobias and Linington, Chris and Hohlfeld, Reinhard and Meinl, Edgar. (2010) Axo-glial antigens as targets in multiple sclerosis : implications for axonal and grey matter injury. Journal of molecular medicine, Vol. 88, no. 8. pp. 753-761.

Gilli, Francesca and Lindberg, Raija L. P. and Valentino, Paola and Marnetto, Fabiana and Malucchi, Simona and Sala, Arianna and Capobianco, Marco and di Sapio, Alessia and Sperli, Francesca and Kappos, Ludwig and Calogero, Raffaele A. and Bertolotto, Antonio. (2010) Learning from nature: pregnancy changes the expression of inflammation-related genes in patients with multiple sclerosis. PLoS ONE, Vol. 5 , e8962.

Kuhle, Jens and Regeniter, Axel and Leppert, David and Mehling, Matthias and Kappos, Ludwig and Lindberg, Raija L. P. and Petzold, Axel. (2010) A highly sensitive electrochemiluminescence immunoassay for the neurofilament heavy chain protein. Journal of neuroimmunology, Vol. 220, H. 1/2. pp. 114-119.

Lindberg, Raija L. P. and Hoffmann, Francine and Mehling, Matthias and Kuhle, Jens and Kappos, Ludwig. (2010) Altered expression of miR-17-5p in CD4+ lymphocytes of relapsing-remitting multiple sclerosis patients. European journal of immunology, Vol. 40, H. 3. pp. 888-898.

Mehling, M. and Lindberg, R. and Raulf, F. and Kuhle, J. and Hess, C. and Kappos, L. and Brinkmann, V.. (2010) Th17 central memory T cells are reduced by FTY720 in patients with multiple sclerosis. Neurology, Vol. 75, H. 5. pp. 403-410.

Pellkofer, Hannah L. and Kuempfel, Tania and Jacobson, Leslie and Vincent, Angela and Derfuss, Tobias. (2010) Non-paraneoplastic limbic encephalitis associated with NMDAR and VGKC antibodies. Journal of neurology, neurosurgery, and psychiatry, Vol. 81, H. 12. pp. 1407-1408.

Ströbel, Simon and Loparic, Marko and Wendt, David and Schenk, Andreas D. and Candrian, Christian and Lindberg, Raija L. P. and Moldovan, Florina and Barbero, Andrea and Martin, Ivan. (2010) Anabolic and catabolic responses of human articular chondrocytes to varying oxygen percentages. Arthritis research & therapy, Vol. 12 , R34.

Baranzini, S. E. and Wang, J. and Gibson, R. A. and Galwey, N. and Naegelin, Y. and Barkhof, F. and Radue, E. W. and Lindberg, R. L. and Uitdehaag, B. M. and Johnson, M. R. and Angelakopoulou, A. and Hall, L. and Richardson, J. C. and Prinjha, R. K. and Gass, A. and Geurts, J. J. and Kragt, J. and Sombekke, M. and Vrenken, H. and Qualley, P. and Lincoln, R. R. and Gomez, R. and Caillier, S. J. and George, M. F. and Mousavi, H. and Guerrero, R. and Okuda, D. T. and Cree, B. A. and Green, A. J. and Waubant, E. and Goodin, D. S. and Pelletier, D. and Matthews, P. M. and Hauser, S. L. and Kappos, L. and Polman, C. H. and Oksenberg, J. R.. (2009) Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. Human molecular genetics, Vol. 18. pp. 767-778.

Baranzini, Sergio E. and Galwey, Nicholas W. and Wang, Joanne and Khankhanian, Pouya and Lindberg, Raija and Pelletier, Daniel and Wu, Wen and Uitdehaag, Bernard M. J. and Kappos, Ludwig and Polman, Chris H. and Matthews, Paul M. and Hauser, Stephen L. and Gibson, Rachel A. and Oksenberg, Jorge R. and Barnes, Michael R.. (2009) Pathway and network-based analysis of genome-wide association studies in multiple sclerosis. Human molecular genetics, Vol. 18. pp. 2078-2090.

Kuhle, J. and Lindberg, R. L. P. and Regeniter, A. and Mehling, M. and Steck, A. J. and Kappos, L. and Czaplinski, A.. (2009) Increased levels of inflammatory chemokines in amyotrophic lateral sclerosis. European journal of neurology, Vol. 16. pp. 771-774.

Farrell, R. and Bendtzen, K. and Bertolotto, A. and Clark, B. and Comabella, M. and Deisenhammer, F. and Fogdell-Hahn, A. and Giovannoni, G. and Hartung, H. P. and Hemmer, B. and Hillert, J. and Kappos, L. and Killestein, J. and Lindberg, R. and Montalban, X. and Polman, C. and Sorensen, P. S. and European, Nabinms Consortium. (2008) Re: Neutralizing antibodies to interferon beta-1b are not associated with disease worsening in multiple sclerosis. Journal of international medical research, Vol. 36, H. 1 , S. 204-208 ; author reply 208-210.

Ishihara, Hideyuki and Kubota, Hisashi and Lindberg, Raija L. P. and Leppert, David and Gloor, Sergio M. and Errede, Mariella and Virgintino, Daniela and Fontana, Adriano and Yonekawa, Yasuhiro and Frei, Karl. (2008) Endothelial cell barrier impairment induced by glioblastomas and transforming growth factor beta2 involves matrix metalloproteinases and tight junction proteins. Journal of neuropathology and experimental neurology, Vol. 67, H. 5. pp. 435-448.

Lindberg, R. L. and Achtnichts, L. and Hoffmann, F. and Kuhle, J. and Kappos, L.. (2008) Natalizumab alters transcriptional expression profiles of blood cell subpopulations of multiple sclerosis patients. Journal of neuroimmunology, Vol. 194. pp. 153-164.

Mehling, M. and Brinkmann, V. and Antel, J. and Bar-Or, A. and Goebels, N. and Vedrine, C. and Kristofic, C. and Kuhle, J. and Lindberg, R. L. and Kappos, L.. (2008) FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis. Neurology, Vol. 71, H. 16. pp. 1261-1267.

This list was generated on Thu Mar 28 03:45:15 2024 CET.